XML 138 R126.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Earnings per share [abstract]      
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (6,039) $ (10,670) $ (12,155)
Non-controlling interest     92
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (6,039) $ (10,670) $ (12,063)
Weighted average number of ordinary shares used in calculating basic earnings per share 48,376,525 467,833,849 427,431,910
Weighted average number of ordinary shares used in calculating diluted earnings per share 48,376,525 467,833,849 427,431,910
Basic earnings per share $ (12.48) $ (2.28) $ (2.82)
Diluted earnings per share $ (12.48) $ (2.28) $ (2.82)